Cotton-O'Neil Clinic

Topeka, Kansas 66606-1670

0 studies enrolling now · 24 studies all time

What they study most

Acute Gout, Alzheimer Disease, Alzheimer Disease (AD), Alzheimer's Disease, Chronic Kidney Disease, Diabetes Mellitus, Type 2, HIV Infections, Low Back Pain, Neuralgia, Postherpetic, Obesity, Osteoarthritis, Overweight

Studies at this site

• A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ) — Completed
• A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2) — Completed
• A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss — Completed
• Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Osteoarthritis — Completed
• A Study of LY3437943 in Participants With Type 2 Diabetes — Completed
• A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease — Completed
• A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes — Completed
• A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone — Completed
• RN624 In Adult Patients With Chronic Low Back Pain — Completed
• RN624 For Pain Of Post-Herpetic Neuralgia — Completed
• Long Term Safety Study of Tanezumab in Chronic Low Back Pain — Stopped early
• A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia — Stopped early
• Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 Diabetes — Completed
• A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia — Stopped early
• A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease — Stopped early
• A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus — Stopped early
• A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM) — Stopped early
• A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes — Completed
• A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD) — Completed
• A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diabetes Mellitus — Completed
• Expanded Access Program for Maraviroc At Multiple Centers — Completed
• Targeted Dose Finding of Canakinumab (ACZ885) for Management of Acute Flare in Refractory or Contraindicated Gout Patients — Completed
• Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off — Stopped early
• Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder — Completed